Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Arthritis, Psoriatic 3Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × guselkumab × Clear all
NCT04936308 2026-06-05

SOLSTICE

Janssen Research & Development, LLC

Phase 3 Active not recruiting
453 enrolled 25 charts

Arthritis, Psoriatic

NCT03649971 2025-02-03

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Janssen Research & Development, LLC

Phase 1 Completed
77 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT03796858 2025-02-03

COSMOS

Janssen Pharmaceutica N.V., Belgium

Phase 3 Completed
285 enrolled

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed
383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡